EA200802210A1 - Замещенные пролинамиды, их получение и их применение в качестве лекарственных средств - Google Patents

Замещенные пролинамиды, их получение и их применение в качестве лекарственных средств

Info

Publication number
EA200802210A1
EA200802210A1 EA200802210A EA200802210A EA200802210A1 EA 200802210 A1 EA200802210 A1 EA 200802210A1 EA 200802210 A EA200802210 A EA 200802210A EA 200802210 A EA200802210 A EA 200802210A EA 200802210 A1 EA200802210 A1 EA 200802210A1
Authority
EA
Eurasian Patent Office
Prior art keywords
substituted
medicines
receiving
prolinamides
salts
Prior art date
Application number
EA200802210A
Other languages
English (en)
Russian (ru)
Inventor
Кай Герлах
Хеннинг Припке
Роланд Пфау
Вольфганг Винен
Аннетте Шулер-Метц
Георг Даманн
Герберт Нар
Original Assignee
Бёрингер Ингельхайм Интернациональ Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Бёрингер Ингельхайм Интернациональ Гмбх filed Critical Бёрингер Ингельхайм Интернациональ Гмбх
Publication of EA200802210A1 publication Critical patent/EA200802210A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
EA200802210A 2006-05-16 2007-05-14 Замещенные пролинамиды, их получение и их применение в качестве лекарственных средств EA200802210A1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06113977 2006-05-16
EP07102566 2007-02-16
PCT/EP2007/054631 WO2007131982A2 (de) 2006-05-16 2007-05-14 Substituierte prolinamide, deren herstellung und deren verwendung als arzneimittel

Publications (1)

Publication Number Publication Date
EA200802210A1 true EA200802210A1 (ru) 2009-06-30

Family

ID=38646563

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200802210A EA200802210A1 (ru) 2006-05-16 2007-05-14 Замещенные пролинамиды, их получение и их применение в качестве лекарственных средств

Country Status (23)

Country Link
US (1) US7807693B2 (cg-RX-API-DMAC7.html)
EP (1) EP2051975B1 (cg-RX-API-DMAC7.html)
JP (1) JP5263686B2 (cg-RX-API-DMAC7.html)
KR (1) KR101422456B1 (cg-RX-API-DMAC7.html)
AR (1) AR060945A1 (cg-RX-API-DMAC7.html)
AU (1) AU2007251614B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0711648A2 (cg-RX-API-DMAC7.html)
CA (1) CA2653753C (cg-RX-API-DMAC7.html)
CL (1) CL2007001391A1 (cg-RX-API-DMAC7.html)
DK (1) DK2051975T3 (cg-RX-API-DMAC7.html)
EA (1) EA200802210A1 (cg-RX-API-DMAC7.html)
EC (1) ECSP088824A (cg-RX-API-DMAC7.html)
ES (1) ES2395538T3 (cg-RX-API-DMAC7.html)
IL (1) IL195245A (cg-RX-API-DMAC7.html)
MX (1) MX2008014499A (cg-RX-API-DMAC7.html)
MY (1) MY146623A (cg-RX-API-DMAC7.html)
NO (1) NO20084530L (cg-RX-API-DMAC7.html)
NZ (1) NZ573573A (cg-RX-API-DMAC7.html)
PE (1) PE20080702A1 (cg-RX-API-DMAC7.html)
PL (1) PL2051975T3 (cg-RX-API-DMAC7.html)
TW (1) TW200813047A (cg-RX-API-DMAC7.html)
UY (1) UY30352A1 (cg-RX-API-DMAC7.html)
WO (1) WO2007131982A2 (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2636050C2 (ru) * 2012-05-24 2017-11-20 Оно Фармасьютикал Ко., Лтд. Замещенные пирролидины в качестве ингибиторов фактора xia для лечения тромбоэмболических заболеваний

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1975165A1 (de) 2007-03-27 2008-10-01 Boehringer Ingelheim Pharma GmbH & Co. KG Substituierte Pyrrolidinamide, deren Herstellung und deren Verwendung als Arzneimittel
WO2009063028A2 (en) 2007-11-15 2009-05-22 Boehringer Ingelheim International Gmbh Substituted amides, manufacturing and use thereof as medicaments
US20110046130A1 (en) * 2008-03-31 2011-02-24 Evotec Ag Tetrahydronaphthyridines and aza derivatives thereof as histamine h3 receptor antagonists
EP2958919B1 (en) 2013-02-21 2019-05-22 Boehringer Ingelheim International GmbH Dihydropteridinones i
JP6337750B2 (ja) * 2013-11-22 2018-06-06 小野薬品工業株式会社 化合物
DK3102576T3 (da) 2014-02-03 2019-07-22 Vitae Pharmaceuticals Llc Dihydropyrrolopyridininhibitorer af ror-gamma
HRP20221373T1 (hr) * 2014-03-07 2023-01-06 Biocryst Pharmaceuticals, Inc. Supstituirani pirazoli kao inhibitori kalikreina u ljudskoj plazmi
SI3207043T1 (sl) 2014-10-14 2019-04-30 Vitae Pharmaceuticals, Inc. Dihidropirolopiridinovi inhibitorji za ROR-gama
US9845308B2 (en) 2014-11-05 2017-12-19 Vitae Pharmaceuticals, Inc. Isoindoline inhibitors of ROR-gamma
US9663515B2 (en) 2014-11-05 2017-05-30 Vitae Pharmaceuticals, Inc. Dihydropyrrolopyridine inhibitors of ROR-gamma
EP3078378B1 (en) 2015-04-08 2020-06-24 Vaiomer Use of factor xa inhibitors for regulating glycemia
EP3331876B1 (en) 2015-08-05 2020-10-07 Vitae Pharmaceuticals, LLC Modulators of ror-gamma
EP3868750A1 (en) 2015-11-20 2021-08-25 Vitae Pharmaceuticals, LLC Modulators of ror-gamma
TWI757266B (zh) 2016-01-29 2022-03-11 美商維它藥物有限責任公司 ROR-γ調節劑
US9481674B1 (en) 2016-06-10 2016-11-01 Vitae Pharmaceuticals, Inc. Dihydropyrrolopyridine inhibitors of ROR-gamma
CN115716826A (zh) 2017-07-24 2023-02-28 生命医药有限责任公司 RORγ的抑制剂
WO2019018975A1 (en) 2017-07-24 2019-01-31 Vitae Pharmaceuticals, Inc. INHIBITORS OF ROR GAMMA
CN114646701B (zh) * 2022-03-01 2023-09-29 浙江国邦药业有限公司 一种l-脯氨酰胺中有关物质的hplc测试方法
CN121311466A (zh) * 2023-04-14 2026-01-09 辉瑞大药厂 葡萄糖依赖性促胰岛素多肽受体拮抗剂及其用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7030141B2 (en) 2001-11-29 2006-04-18 Christopher Franklin Bigge Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade
JP3975254B2 (ja) * 2002-07-25 2007-09-12 日野自動車株式会社 チャイルドシート用アンカの取付構造
PL377633A1 (pl) 2003-04-03 2006-02-06 Merck Patent Gmbh Związki karbonylowe
DE10329457A1 (de) * 2003-04-03 2005-01-20 Merck Patent Gmbh Ethinylprolinderivate
US7557222B2 (en) * 2003-06-18 2009-07-07 Merck Patent Gmbh 1-[(4-Ethynylphenyl)]-2-[(phenyl)]-pyrrolidine-1,2-dicarboxamide derivatives as inhibitors of coagulation factors Xa and VIIa for the treatment of thrombosis
ES2223277B1 (es) 2003-06-19 2006-03-01 Fernando Bouffard Fita Composicion anestesica para administracion topica.
DE10358814A1 (de) * 2003-12-16 2005-07-21 Merck Patent Gmbh Prolinylarylacetamide
DE102004014945A1 (de) 2004-03-26 2005-10-13 Merck Patent Gmbh Prolinylderivate
US7453002B2 (en) * 2004-06-15 2008-11-18 Bristol-Myers Squibb Company Five-membered heterocycles useful as serine protease inhibitors
DE102004045796A1 (de) 2004-09-22 2006-03-23 Merck Patent Gmbh Arzneimittel enthaltend Carbonylverbindungen sowie deren Verwendung
EP1869010A1 (en) 2005-04-11 2007-12-26 Glaxo Group Limited 3-sulfonylamino-pyrrolidine-2-one derivatives as factor xa inhibitors
AU2006271781A1 (en) * 2005-07-15 2007-01-25 F. Hoffmann-La Roche Ag Novel heteroaryl fused cyclic amines

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2636050C2 (ru) * 2012-05-24 2017-11-20 Оно Фармасьютикал Ко., Лтд. Замещенные пирролидины в качестве ингибиторов фактора xia для лечения тромбоэмболических заболеваний

Also Published As

Publication number Publication date
CA2653753C (en) 2013-09-24
PE20080702A1 (es) 2008-07-10
IL195245A (en) 2012-09-24
AU2007251614B2 (en) 2013-01-17
DK2051975T3 (da) 2012-10-15
JP5263686B2 (ja) 2013-08-14
WO2007131982A2 (de) 2007-11-22
US20080139605A1 (en) 2008-06-12
MY146623A (en) 2012-09-14
AU2007251614A1 (en) 2007-11-22
AR060945A1 (es) 2008-07-23
EP2051975B1 (de) 2012-09-12
EP2051975A2 (de) 2009-04-29
US7807693B2 (en) 2010-10-05
TW200813047A (en) 2008-03-16
KR101422456B1 (ko) 2014-07-23
CA2653753A1 (en) 2007-11-22
HK1131140A1 (en) 2010-01-15
CL2007001391A1 (es) 2008-01-18
PL2051975T3 (pl) 2013-01-31
KR20090017523A (ko) 2009-02-18
UY30352A1 (es) 2008-01-02
MX2008014499A (es) 2008-11-27
WO2007131982A3 (de) 2008-01-10
ECSP088824A (es) 2008-11-27
IL195245A0 (en) 2009-09-22
ES2395538T3 (es) 2013-02-13
NZ573573A (en) 2011-10-28
BRPI0711648A2 (pt) 2011-11-29
NO20084530L (no) 2008-12-12
JP2009537483A (ja) 2009-10-29

Similar Documents

Publication Publication Date Title
EA201000612A1 (ru) Антагонисты cgrp-пептиды
UY30979A1 (es) Pirrolidinamidas sustituidas, su preparacion y su uso como medicamentos
WO2007131982A3 (de) Substituierte prolinamide, deren herstellung und deren verwendung als arzneimittel
ECSP078058A (es) Nuevas glicinamidas sustituidas, su preparación y su uso como medicamentos
EA201101209A1 (ru) Соединения в качестве антагонистов брадикинина b1
EA200701396A1 (ru) Триазолофталазины в качестве ингибиторов pde-2
EA201170772A1 (ru) Органические соединения
UA87153C2 (ru) Энантиомерно чистые аминогетероарильные соединения как ингибиторы протеинкиназы
ATE548374T1 (de) 2'-fluor-2'-desoxytetrahydrouridine als cytidindeaminaseinhibitoren
EA201100037A1 (ru) Органические соединения
EA200800321A1 (ru) Ингибиторы гистондеацетилазы
EA201001359A1 (ru) Гетероциклические соединения в качестве ингибиторов cxcr2
EA201000550A1 (ru) Производные тиазола
UY28773A1 (es) Nuevas amidas de ácidos carboxílicos, su preparación y su uso como medicamentos.
EA201000296A1 (ru) Новые соединения
ATE471324T1 (de) Triazolophthalazine
EA200601568A1 (ru) Новые гидрокси-8-гетероарилфенантридины и их применение в качестве ингибиторов pde4
EA201000069A1 (ru) Новые гербициды
EA201001348A1 (ru) Пирролопиримидинкарбоксамиды
EA200801199A1 (ru) Ингибиторы киназы
EA200500261A1 (ru) Новые пролекарства (n-2-пиридил-n-2-гидроксикарбонилэтил)амида 1-метил-2-(4-амидинофениламинометил)бензимидазол-5-илкарбоновой кислоты, их получение и их применение в качестве лекарственных средств
EA200901504A1 (ru) Производные пиразолона, как ингибиторы pde4
TW200700358A (en) Organic compounds
EA201001517A1 (ru) Замещенные пиперидины в качестве терапевтических соединений
GB0602951D0 (en) Organic Compounds